Telescope Innovations Corp. is a chemical technology company that specializes in developing advanced manufacturing processes and automation tools for the pharmaceutical, chemical, and critical materials sectors. The company's core focus lies in leveraging robotics, artificial intelligence, and advanced analytics to accelerate chemical process development and enhance research efficiency. Its technology portfolio includes flexible automation platforms and unique software solutions designed to reduce the cost and complexity of R&D, manufacturing, and commercial deployment within the life sciences and industrial sectors.
Telescope Innovations partners with leading pharmaceutical firms, mining companies, engineering consultancies, and government agencies to address industry-driven challenges. Notably, the company has introduced products such as the DirectInject-LC™ platform, adopted globally by top pharmaceutical enterprises, and has pioneered proprietary manufacturing processes like the low-temperature DualPure™ method for battery-grade lithium sulfide. With a leadership team featuring recognized scientific experts and advisors, Telescope Innovations has built a reputation for innovation in chemical process automation. Headquartered in Vancouver, Canada, the company plays a growing role in streamlining the development of new therapies, materials, and industrial chemicals, positioning itself at the intersection of biotechnology and advanced manufacturing technology.
Markedsdata leveret af TwelveData og Morningstar